| Potentially Avoidable Hospitalisation in France (NCT02898155) | University Hospital, Montpellier | 2016-06-01 |
| Meta-Analyses of Low-risk Lifestyle Behaviours and Patient Important Outcomes (NCT03234101) | University of Toronto | 2016-06-01 |
| Predicting Hypoglycaemia and Arrhythmias in the Patient With Diabetes and CKD - Validation Study (NCT02778269) | RWTH Aachen University | 2016-06-01 |
| Plerixafor in Diabetic Wound Healing (NCT02790957) | Gian Paolo Fadini | 2016-06-01 |
| Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy (NCT02798757) | University of Ioannina | 2016-06-01 |
| Carefully seLected and Easily Accessible at No Charge Medications (NCT02744963) | Unity Health Toronto | 2016-06-01 |
| Lifestyle Changes Through Exercise and Nutrition (NCT02863887) | Pennington Biomedical Research Center | 2016-06-01 |
| Families on Track: A Digital Health Behavioral Intervention for Parents Seeking Treatment for Their Child With Obesity (NCT02767440) | Duke University | 2016-06-01 |
| Leiden University Medical Center Mini Donor Bank (NCT02810613) | Leiden University Medical Center | 2016-05-31 |
| A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus (NCT02773368) | Novo Nordisk A/S | 2016-05-23 |
| Preventing Diabetes in Latino Youth (NCT02615353) | Arizona State University | 2016-05-13 |
| Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes (NCT02500706) | Novo Nordisk A/S | 2016-05-04 |
| Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes (NCT02670915) | Novo Nordisk A/S | 2016-05-04 |
| Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes (NCT02762578) | Novo Nordisk A/S | 2016-05-03 |
| Effect of Apelin on Insulin Sensitivity in Type 2 Diabetic Volunteers (NCT02724566) | University Hospital, Toulouse | 2016-05-01 |
| Role of Interrupting Sedentary Time in Management of Type-2 Diabetes (NCT02738996) | Glasgow Caledonian University | 2016-05-01 |
| OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO (NCT02819011) | Bijan Najafi, PhD | 2016-05-01 |
| Low Glycemic Diet Intervention and Community Diabetic Patients (NCT02575937) | Sun Yat-sen University | 2016-05-01 |
| A Study of the Effectiveness of Xultophy® (Insulin Degludec/Liraglutide) in an Adult Real-world Population With Type 2 Diabetes Mellitus (NCT02754817) | Novo Nordisk A/S | 2016-04-26 |
| Patient-Centred Innovations for Persons With Multimorbidity - Quebec (NCT02789800) | Université de Sherbrooke | 2016-04-22 |
| Bauhinia Forficata in Diabetic Patients (NCT02760017) | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | 2016-04-01 |
| Do Patient-Centric mHealth Programs Improve Patient Engagement and Health Outcomes. (NCT02757183) | AnalyticsPlus, Inc. | 2016-04-01 |
| Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems (NCT02868983) | University of Vermont | 2016-04-01 |
| Transforming Primary Care Payment in Hawaii (NCT02731716) | University of Pennsylvania | 2016-04-01 |
| Clinical Study, Opened, of Cutaneous Acceptability of a Topic Product in Normal Conditions of Use (NCT02695706) | LM Farma Indústria e Comércio Ltda. | 2016-04-01 |
| mWELLCARE:An Integrated mHealth System for the Prevention and Care of Chronic Disease (NCT02480062) | Public Health Foundation of India | 2016-04-01 |
| Diabetes and Palliative Care (NCT02742701) | Maison Médicale Jeanne Garnier | 2016-04-01 |
| Peer-Supported Diabetes Self-Management Support (NCT02746861) | InquisitHealth, Inc. | 2016-04-01 |
| Daily Glycaemic Variability in Frail or Disabled Older Patients With Diabetes Over 75 Treated With Basal Insulin (NCT02486341) | University Hospital, Bordeaux | 2016-03-31 |
| Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes (NCT02730377) | Novo Nordisk A/S | 2016-03-28 |
| Hyperglycemia and Mitochondrial Function in The Endothelium of Humans (NCT02682342) | Medical College of Wisconsin | 2016-03-09 |
| Community-Based Lifestyle Intervention for Primary and Secondary Prevention of Diabetes in Arab Women in East-Jerusalem (NCT04143737) | Hadassah Medical Organization | 2016-03-07 |
| Guangzhou Women's Health Cohort Study (GWHCS) (NCT05506800) | Guangzhou Women and Children's Medical Center | 2016-03-03 |
| The Manitoba Personalized Lifestyle Research (TMPLR) Study (NCT03674957) | University of Manitoba | 2016-03-01 |
| Single-dose Study to Evaluate Safety, Tolerability, and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus (NCT02715193) | REMD Biotherapeutics, Inc. | 2016-03-01 |
| Involvement of Community Pharmacists in Complex Care Plans for Diabetic Patients, a Pilot Study (NCT02399332) | University of Calgary | 2016-03-01 |
| NYULMC CareSmarts Pilot (NCT02726217) | NYU Langone Health | 2016-03-01 |
| System Accuracy Evaluation of 2 CE-marked Blood Glucose Monitoring System (NCT02710617) | Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm | 2016-03-01 |
| Study of the Reliability of a Device (HumanSens Plus) Allowing Immediate Measurement Uric Acid in the Blood Obtained by Finger Tip Puncture. (NCT02671656) | Assistance Publique - Hôpitaux de Paris | 2016-03-01 |
| A Patient-Centered PaTH to Addressing Diabetes (NCT02788903) | Milton S. Hershey Medical Center | 2016-03-01 |
| Cardiovascular Health Promotion Among African-Americans by FAITH! (NCT03084822) | Mayo Clinic | 2016-03-01 |
| Feasibility of REHIT in NDH Patients (NCT04011397) | University of Huddersfield | 2016-03-01 |
| Impact of Branched-chain Amino Acids in the Development of Insulin Resistance (NCT03261362) | German Diabetes Center | 2016-03-01 |
| Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes) (NCT02838693) | Medicine | 2016-03-01 |
| The Effect of Hypocaloric Diet Associated With tDCS on Weight Loss and Metabolic Profile (NCT02683902) | Hospital de Clinicas de Porto Alegre | 2016-03-01 |
| Tedizolid Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis (NCT02620787) | Hartford Hospital | 2016-02-23 |
| Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome (NCT02739217) | Liminal BioSciences Ltd. | 2016-02-22 |
| Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections (NCT02620774) | Hartford Hospital | 2016-02-19 |
| Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes (NCT02607865) | Novo Nordisk A/S | 2016-02-15 |
| Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP) (NCT02673866) | Daiichi Sankyo | 2016-02-01 |
| Investigation Into the Effects of Blood Glucose Levels Upon Eating Behavior in Lean and Obese Non-diabetic and Diabetic Subjects (NCT02673203) | Yale University | 2016-02-01 |
| A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus (NCT02501161) | Novo Nordisk A/S | 2016-01-31 |
| Stand & Move at Work (NCT02566317) | Arizona State University | 2016-01-15 |
| Patient-Centred Innovations for Persons With Multimorbidity - Ontario (NCT02742597) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-01-12 |
| Liquid or Solid State of Food on Glycaemia, Lipaemia and Insulinaemia (NCT02875275) | Singapore Institute of Food and Biotechnology Innovation | 2016-01-12 |
| Bariatric Surgery and Fatty Liver Disease (NCT04569396) | University Hospital Ostrava | 2016-01-12 |
| Quantitative Assessment and Characterization of Microvascular Function Using Diffuse Optical Tomography (NCT03411213) | Sheffield Teaching Hospitals NHS Foundation Trust | 2016-01-11 |
| Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes. (NCT02648204) | Novo Nordisk A/S | 2016-01-06 |
| Water-soluble Ubiquinol Supplementation on Blood Glucose, Lipids, Oxidative Stress, and Inflammation in Diabetes (NCT02622672) | Yeh | 2016-01-04 |
| Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan (NCT02648217) | Novo Nordisk A/S | 2016-01-04 |
| Post Trial Analysis of a Primary Prevention Study in Asian Indians (NCT02848547) | India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals | 2016-01-01 |
| Controlling Hyperglycemia Among Minority Population (NCT02681718) | Sinai Health System | 2016-01-01 |
| Urinary Incontinence and Endocrine Factors. A Part of Lolland-Falster Health Study (LOFUS). (NCT04279184) | Nykøbing Falster County Hospital | 2016-01-01 |
| The Effect of Dopamine on Diabetic Retinopathy (NCT02706977) | Emory University | 2016-01-01 |
| The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study) (NCT02663544) | Fred Hutchinson Cancer Center | 2016-01-01 |
| Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection) (NCT02663388) | University of Lorraine | 2016-01-01 |
| Behavioral Economic Incentives to Improve Glycemic Control Among Adolescents and Young Adults (NCT02568501) | University of Pennsylvania | 2016-01-01 |
| Behavioral Economics in Provider Incentive Design (NCT02634879) | University of Pennsylvania | 2016-01-01 |
| Unidas Por la Vida: A Healthy Lifestyle Intervention for High-risk Latina Dyads (NCT02741037) | University of California, Irvine | 2016-01-01 |
| Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C) (NCT02597127) | The Medicines Company | 2016-01-01 |
| Sí Texas Hope Family Health Center (NCT03916016) | Health Resources in Action, Inc. | 2015-12-09 |
| Investigating the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus (NCT02662114) | Novo Nordisk A/S | 2015-12-08 |
| Noninvasive Glucose Measurements - Database and Calibration Compilation (NCT03368209) | RSP Systems A/S | 2015-12-04 |
| A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen® (NCT02627287) | Novo Nordisk A/S | 2015-12-01 |
| Screening and Characterization of Hearing Disorders in Diabetic Persons (NCT03437135) | University Hospital, Clermont-Ferrand | 2015-12-01 |
| Effect of Olives on Glycaemic Response in Vivo (NCT02669693) | University of Leeds | 2015-12-01 |
| p53 Gene Therapy in Treatment of Diabetes Concurrent With Hepatocellular Carcinoma (NCT02561546) | Shenzhen SiBiono GeneTech Co.,Ltd | 2015-12-01 |
| Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects (NCT02621489) | Karolinska Institutet | 2015-12-01 |
| Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India (NCT02230618) | Novo Nordisk A/S | 2015-11-24 |
| Reverse Colocated Integrated Care Intervention Among Persons With Severe Persistent Mental Illness at US-Mexico Border (NCT03881657) | Health Resources in Action, Inc. | 2015-11-24 |
| Development of Pre-pregnancy Intervention to Reduce the Risk of Diabetes and Prediabetes (NCT02617693) | Novo Nordisk A/S | 2015-11-23 |
| A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus. (NCT02607306) | Novo Nordisk A/S | 2015-11-18 |
| A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function (NCT02443155) | Novo Nordisk A/S | 2015-11-10 |
| A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes (NCT02612844) | Novo Nordisk A/S | 2015-11-01 |
| Initial Combination of Gemigliptin and Metformin on Microbiota Change (NCT02609815) | Seoul National University Bundang Hospital | 2015-11-01 |
| Growing Resilience in Wind River Indian Reservation (NCT02672748) | University of Wyoming | 2015-11-01 |
| Diabetes Risk Reduction Through Eat, Walk, Sleep and Medication Therapy Management for Depressed Cambodians (NCT02502929) | UConn Health | 2015-11-01 |
| Community Health Assessment Program in the Philippines (NCT02479516) | McMaster University | 2015-11-01 |
| A Series of Systematic Reviews and Meta-analyses of the Effect of Vegetarian/Vegan Diets on Cardiometabolic Risk (NCT02600377) | University of Toronto | 2015-11-01 |
| Effect of Dapagliflozin on Vascular Functions in Patients With Type 2 Diabetes Compared to Gliclazide (NCT02610088) | Seoul National University Bundang Hospital | 2015-11-01 |
| Evaluation of an Ascensia Lancing System (NCT02606838) | Ascensia Diabetes Care | 2015-11-01 |
| Mobile Phone-based Intervention for Promoting Healthy Habits and Weight Loss (NCT02621008) | Eco Fusion | 2015-11-01 |
| Blood Sugar Responses by Physical Activity Level and Intensity (NCT02587780) | Small Changes | 2015-11-01 |
| Renal Denervation in Diabetes. (NCT02081989) | Monash University | 2015-11-01 |
| Mindfulness-based Cognitive Therapy to Improve Emotional Wellbeing and Glycaemic Control in Diabetes (NCT02600091) | University of Aberdeen | 2015-10-30 |
| A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles (NCT02594033) | Novo Nordisk A/S | 2015-10-27 |
| Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes (NCT02568280) | Novo Nordisk A/S | 2015-10-06 |
| Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction (NCT02590822) | University of Leicester | 2015-10-02 |
| Acceptance and Value Based Methods in Increasing Wellbeing of Adolescents With Type 1 Diabetes (NCT03825562) | Central Finland Hospital District | 2015-10-01 |
| Healthy.io Method Comparison & User Performance Study (NCT02785445) | Healthy.io Ltd. | 2015-10-01 |